ATRY — Atrys Health SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €218.69m
- €368.42m
- €201.57m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.207 | -1.31 | -24.9 | -24.7 | -33.7 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.97 | 97.5 | 18.7 | 7.45 | 27.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2 | -101 | -9.9 | -28.5 | -28 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1.08 | -1.4 | 4.69 | -15.4 | -1.09 |
Capital Expenditures | -4.8 | -5.29 | -8.57 | -15.2 | -13.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -16.3 | -46.8 | 6.12 | -65.4 | 13.5 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -21.1 | -52.1 | -2.45 | -80.6 | 0.395 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18.6 | 62.6 | 14.1 | 94.8 | 8.19 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.43 | 9.15 | 17.6 | -0.831 | 7.53 |